[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100581703":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":24,"centralContacts":28,"locations":34,"responsibleParty":56,"collaborators":24,"id":60,"slug":24,"hasResults":61,"nctId":62,"briefTitle":63,"officialTitle":64,"acronym":24,"eligibilityCriteria":65,"healthyVolunteers":61,"sex":66,"minAge":67,"maxAge":68,"enrollmentInfo":69,"targetDuration":24,"studyType":72,"phases":73,"briefSummary":75,"conditions":76,"keywords":24,"overallStatus":36,"whyStopped":24,"lastUpdateSubmitDate":82,"lastUpdatePostDateStruct":83,"startDateStruct":86,"completionDateStruct":88,"leadSponsor":90,"locationsCount":91},{"fullName":5,"class":6},"Tanta University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Ambu Auragain group","EXPERIMENTAL","Ambu Auragain was inserted after induction.",[13],"Device: Ambu Auragain",{"label":15,"type":10,"description":16,"interventionNames":17},"I-gel group","The I-gel device was inserted after induction.",[18],"Device: I-gel",[20,25],{"type":21,"name":22,"description":11,"armGroupLabels":23,"otherNames":24},"DEVICE","Ambu Auragain",[9],null,{"type":21,"name":26,"description":16,"armGroupLabels":27,"otherNames":24},"I-gel",[15],[29],{"name":30,"role":31,"phone":32,"phoneExt":24,"email":33},"Aya N Farahat, MBBCH","CONTACT","00201552122249","aya.nabil311.nabil@gmail.com",[35],{"facility":5,"status":36,"city":37,"state":38,"zip":39,"country":40,"cosmosGeoPoint":41,"geoPoint":46,"contacts":47},"RECRUITING","Tanta","El-Gharbia","31527","Egypt",{"type":42,"coordinates":43},"Point",[44,45],31.00192,30.78847,{"lat":45,"lon":44},[48,49,52,54],{"name":30,"role":31,"phone":32,"phoneExt":24,"email":33},{"name":50,"role":51,"phone":24,"phoneExt":24,"email":24},"Kamal E Hikel, MD","SUB_INVESTIGATOR",{"name":53,"role":51,"phone":24,"phoneExt":24,"email":24},"Shaimaa F Abdelkader, MD",{"name":55,"role":51,"phone":24,"phoneExt":24,"email":24},"Maram I Elmazny, MD",{"type":57,"investigatorFullName":58,"investigatorTitle":59,"investigatorAffiliation":5,"oldNameTitle":24,"oldOrganization":24},"PRINCIPAL_INVESTIGATOR","Aya Nabil Farahat","Resident of Anesthesiology, Surgical Intensive Care and Pain Medicine, Faculty of Medicine, Tanta University, Tanta, Egypt.","100581703",false,"NCT06853756","Gastric Insufflation Volume Using I-gel Versus Ambu AuraGain in Pediatric Patients Undergoing Elective Orthopedic Operations Under General Anesthesia","Gastric Insufflation Volume Using I-gel Versus Ambu AuraGain in Pediatric Patients Undergoing Elective Orthopedic Operations Under General Anesthesia: a Prospective Randomized Trial","Inclusion Criteria:\n\n* Aged from 2 to 12 years.\n* Both sexes.\n* American Society of Anesthesiologists (ASA) physical status I and II.\n* Scheduled for elective orthopedic operations in a supine position under general anesthesia.\n\nExclusion Criteria:\n\n* Patients with a known history of gastro-oesophageal reflux disorders.\n* Full Stomach.\n* Anticipated difficult mask ventilation or intubation.\n* Body mass index \"BMI\" exceeding 20% of the ideal.\n* A history of chest problems.\n* History of the gastrointestinal tract or thoracic surgeries.","ALL","2 Years","12 Years",{"count":70,"type":71},60,"ESTIMATED","INTERVENTIONAL",[74],"NA","Our study aimed to compare the gastric insufflation volume between Ambu AuraGain and i-gel and its relationship with the oropharyngeal sealing pressure and the incidence of postoperative complications in generally anesthetized controlled-ventilated pediatric patients undergoing elective orthopedic operations.",[77,26,78,79,80,81],"Gastric Insufflation","Ambu AuraGain","Pediatric","Orthopedic Operations","General Anesthesia","2025-02-25",{"date":84,"type":85},"2025-03-03","ACTUAL",{"date":87,"type":85},"2023-08-01",{"date":89,"type":71},"2025-03-27",{"name":5,"class":6},1]